American Journal of Hematology (AJH) is a scholarly journal dedicated to publishing research in the field of Medicine. John Wiley and Sons is the publisher of this esteemed journal. The P-ISSN assigned to American Journal of Hematology is 0361-8609 and its abbreviated form is Am J Hematol.
The American Journal of Hematology provides broad coverage of experimental and clinical features of blood diseases in humans and in animal models of human disease. The journal publishes original contributions in non-malignant and malignant hematological diseases including clinical and basic studies in hemostasis and thrombosis, immunology, blood banking, and stem cell biology. Clinical translational reports describing novel therapeutic approaches to diagnosis and treatment of hematological diseases are welcomed and encouraged. The journal includes regular original laboratory and clinical research articles, brief research reports, critical reviews, images in hematology, letters and correspondence.
Journal title | American Journal of Hematology (AJH) |
Abbreviation | Am J Hematol |
Print ISSN | 0361-8609 |
Online ISSN | 1096-8652 |
Publisher Name | John Wiley and Sons |
Editor-in-chief | Carlo Brugnara |
Subject Category | Medicine |
Abbreviation : ISO Journal abbreviation refers to the shortened form or acronym used to represent the full title of a scholarly journal. The ISO4 Abbreviation of American Journal of Hematology Journal is Am J Hematol.
The Ranking of the Journal in 2024 is 657. Ranking systems aim to provide an indication of a journal's quality, influence, and prestige within a specific field or discipline.
The Journal's Impact Factor in 2024 is 12.8. it is all calculated by Clarivate, which means how many times a particular citation has been published in the past two years.
The Journal SCImago in 2024 is 2.901. It is measured by the number of citations which are made by the particular journals, and the journal from where the citations arrived from.
The Acceptance Rate in 2024 is 21%. It is a measure that provides insight into the selectivity and competitiveness of a journal's editorial process.
The Journal's H-Index in 2024 is 121. The H-index is calculated on how many times a particular author is cited and the number of published papers that a particular author has.
The Journal's Quartile is Q1. A quartile has three points, which are the upper quartile, median, and lower quartile. The main motive of the quartile is to calculate the interquartile range, that resembles the changes across the median.
The Journal is indexed in (Indexing details)
PubMed | Scopus | Web of Science | UGC | Embase | DOAJ |
---|---|---|---|---|---|
✅ | ✅ | ✅ | ✅ | ❌ | ❌ |
Indexing services aim to make it easier for researchers, scholars, and readers to discover and access articles from various journals within a specific field or discipline.
Abbreviation | Am J Hematol |
Access type | Hybrid |
Acceptance rate | 21% |
Impact Factor | 12.8 |
SJR | 2.901 |
SNIP | 2.714 |
Ranking | 657 |
CiteScore | 15.1 |
H-Index | 121 |
Processing/Submission Fee : Article submission/Processing fees (APC), also known as manuscript Publication fees or processing fees (APC), are charged by journals to authors for submitting/publishing their research papers/article.
The APC/Submission (Publication) Fee of the Journal is $5,190 USD / £3,460 GBP / €4,330 EUR
Call for paper : The Journal invites original research contributions for consideration of publication in American Journal of Hematology journal.
Journal seeking submissions in the broad areas of Medicine that align with journal's focus on Medicine.
for details about call for paper please visit to the official website of the journal to check the details about call for papers.
Publishing in American Journal of Hematology involves the following steps:
Yes, the journal is indexed in PubMed.
Yes, the journal is indexed in Scopus.
Yes, the journal is indexed in UGC.
No, the journal is not indexed in Index copernicus.
No, journal is not a predatory journal.
The Impact Factor of the Journal is 12.8.
The Ranking of the Journal is 657.
Yes the journal is a peer-reviewed journal.
Yes the journal is a peer-reviewed journal and good to publish your paper.
American Journal of Hematology (AJH) is a scholarly journal dedicated to publishing research in the field of Medicine. John Wiley and Sons is the publisher of this esteemed journal.
Yes, American Journal of Hematology is a open access (Hybrid) journal.